Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record for pegzilarginase plus pembrolizumab is displayed, including its terminated status, study design, eligibility criteria, locations, outcomes, and supporting documents. The previous access-denied error is no longer shown.
    Difference
    60%
    Check dated 2026-11-11T01:12:44.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:26:32.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes appears above the page, and the footer revision advances from v3.7.1 to v3.7.2; the study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T23:06:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.0 to v3.7.1; the study record page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:24:15.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error and minimal navigation (including a Home link), replacing the previous study content and metadata.
    Difference
    18%
    Check dated 2026-09-22T23:23:46.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0 in the footer. This reflects an update to the page software/versioning without changing the study details.
    Difference
    0.1%
    Check dated 2026-09-15T22:06:00.000Z thumbnail image

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.